Información de la publicación

Portal del Investigador > Publicaciones > detalle publicacion

Detalle_Publicacion

Bendamustine, etoposide, cytarabine, melphalan, and autologous stem cell rescue produce a 72% 3-year PFS in resistant lymphoma.

Otras publicaciones de la misma revista o congreso con autores/as de la Universidad de Cantabria

Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development - Artículo de Revista
Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome - Artículo de Revista
Randomized phase 2 study of weekly carfilzomib 70 Mg/m2 and dexamethasone plus/minus cyclophosphamide in relapsed and/or refractory multiple myeloma (RRMM) patients (GEM-KyCyDex) - Artículo de Revista
Hnrnpk overexpression drives nucleolar aberrancies causing ribosomopathies - Comunicación a Congreso
Genetic subtyping using whole exome sequencing across large B cell lymphoma entities in a series of 109 DLBCL and plasmablastic lymphoma cases - Comunicación a Congreso
Results from the cohort-expansion stage of a phase I trial of tinostamustine monotherapy in advanced Hodgkin Lymphoma (HL), Non-Hodgkin Lymphoma (NHL) and multiple myeloma (MM) (NCT02576496) - Comunicación a Congreso
30-minute infusion of isatuximab in newly diagnosed multiple myeloma (NDMM) patients: results of a phase 1b study - Comunicación a Congreso
BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients. - Artículo de Revista
The clinical utility and prognostic value of multiparameter flow cytometry immunophenotyping in light-chain amyloidosis. - Artículo de Revista
Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile. - Artículo de Revista
Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma. - Artículo de Revista
Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies - Artículo de Revista
Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations - Artículo de Revista
Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia - Artículo de Revista
Natural history and cell of origin of TC F3- ZN F384 and PTPN11 mutations in monozygotic twins with concordant BCP-ALL - Artículo de Revista
Discovery of a CD10-negative B-progenitor in human fetal life identifies unique ontogeny-related developmental programs - Artículo de Revista
PLCG1 mutations in cutaneous T-cell lymphomas - Artículo de Revista

Fuente: Blood, 2014, 124(19), 3029-3031

Editorial: American Society of Hematology

Año de publicación: 2014

Nº de páginas: 3

Tipo de publicación: Artículo de Revista

DOI: 10.1182/blood-2014-08-596668

ISSN: 0006-4971,1528-0020

Leer publicación

Autoría

VISANI, GIUSEPPE

STEFANI, PIETRO MARIA

CAPRIA, SAVERIA

MALERBA, LARA

GALIENI, PIERO

GAUDIO, FRANCESCO

SPECCHIA, GIORGINA

MELONI, GIOVANNA

GHERLINZONI, FILIPPO

GONELLA, ROBERTA

GOBBI, MARCO

SANTORO, ARMANDO

FERRARA, FELICETTO

ROCCHI, MARCO

ENRIQUE MARIA OCIO SAN MIGUEL

CABALLERO, MARIA DOLORES

LOSCOCCO, FEDERICA

ISIDORI, ALESSANDRO

Descargar referencia

Bib Ris

Volver

Researchers portal

Portal del personal investigador

Detalle_Publicacion

Bendamustine, etoposide, cytarabine, melphalan, and autologous stem cell rescue produce a 72% 3-year PFS in resistant lymphoma.

Autoría

Descargar referencia